| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |